The COVID-19 vaccine scene in India is gaining momentum. The Indian council of Medical Research (ICMR) plans to launch the indigenous vaccine for COVID-19 by August 15 after the completion of the clinical trials. It has selected 13 institutions across the country for clinical trials and asked them to initiate subject enrollment by July 7. ICMR has partnered with Hyderabad-based Bharat Biotech International Limited (BBIL) to fast-track clinical trials of the BBV152 COVID vaccine. The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology Pune. ICMR and BBIL are jointly working for the preclinical as